Scott Younger
Director, Disease Gene Engineering, Children’s Mercy Research Institute
Scott Younger is listed as Director, Disease Gene Engineering, Children’s Mercy Research Institute. Scott is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Scott. Is this you? Claim this profile.
About
Scott Younger, Ph.D., is the Director of Disease Gene Engineering within the Genomic Medicine Center at Children's Mercy Kansas City. His laboratory is focused on dissecting the molecular mechanisms through which rare genetic variants identified in patients at Children's Mercy lead to disease. Younger joined Children's Mercy from the Broad Institute of MIT and Harvard where his group worked on the development of new methodologies to expand the utility of CRISPR-based genetic screens. Prior to working at the Broad Institute, he completed his postdoctoral studies at Harvard University as an American Cancer Society Fellow. He holds a Ph.D. in cell and molecular biology from UT Southwestern Medical Center. He also received an M.S. in biotechnology from the University of Texas at San Antonio and a B.S.I. in bioinformatics from Baylor University.
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Genome Editing and AI-Driven Approaches in Drug Discovery and Target Validation Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Scott at events on B2DB.
- Davide Gianni Senior Director · AstraZeneca 1 shared session
- Sam Hasson Senior Director, Target Biology · Rgenta Therapeutics 1 shared session